SANSTRAT Announces the Launch of India’s First Strategic Advisory Firm Focused Exclusively on the IVD Sector Bangalore, India — Sanstrat is excited to announce its official launch as the only strategic advisory firm in India dedicated exclusively to the In Vitro Diagnostics (IVD) sector. With a specific focus on supporting global companies to establish and […]
The Indian In-Vitro Diagnostic (IVD) industry has been on a robust growth trajectory, expanding at an average rate of 15% annually over the past 30 years. By 2025, the market size for IVD products in India is projected to reach USD 1.5 billion. This vibrant market is home to over a hundred IVD companies, from
STRATEGY DETERMINES SUCCESS: Navigating the Indian In Vitro Diagnostic (IVD) Market Read More »
Point-of-care testing (POCT) refers to diagnostic testing that takes place near the patient, typically in settings like a doctor’s office/clinic or hospital, with results available within minutes. The goal is to deliver faster results, which facilitates quicker decision-making regarding treatment. The Indian Point-of-Care (POC) testing market is experiencing significant growth, expanding at an annual rate
Point-of-Care Testing: A Significant Opportunity in the Indian Market Read More »
https://economictimes.indiatimes.com/news/economy/foreign-trade/india-eu-trade-put-firmly-on-track-big-news-expected-within-this-year/articleshow/118619078.cms? Optimism in the air !As trade barriers break, technology becomes accessible ! In-Vitro Diagnostic companies across India and EU would benefit from easier access to each others market. This benefits the patients as well as the health care professional who would be able to access newer technology for earlier and accurate diagnosis. India is
India-EU Free Trade Agreement : Impact on IVD Read More »
